首页> 外国专利> USE OF SUBSTITUTED 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO1,2-a PYRIMIDIN-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO1,2-a PYRIMIDIN-5(1H)ONE DERIVATIVES AS THERAPEUTIC AGENTS

USE OF SUBSTITUTED 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO1,2-a PYRIMIDIN-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO1,2-a PYRIMIDIN-5(1H)ONE DERIVATIVES AS THERAPEUTIC AGENTS

机译:取代的2-吡啶基-6,7,8,9-四氢嘧啶基[1,2-a]吡喃酮-4-酮和7-吡啶基-2,3-二羟基咪唑[1,2-a]吡喃酮-5(1H)的使用一种衍生物作为治疗剂

摘要

The invention relates to an use of pyrimidone derivative represented by formula (I) or a salt thereof: embedded imagewherein m, n, p, X, Y, R1, R2, R3, R4 and R5 are as defined herein for treating a variety of disease states. More specifically, the invention relates to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3β or GSK3β and cdk5/p25, such as Alzheimer's disease.
机译:本发明涉及式(I)代表的嘧啶酮衍生物或其盐的用途: <图像alt =“嵌入式图像” file =“ US20070167461A1-20070719-C00001.GIF” he =“ 34.71mm” imgContent =“ chem” imgFormat =“ GIF” wi =“ 61.13mm“ /> 其中m,n,p,X,Y,R 1,R 2,R 3,R 4和R 5如本文所定义,用于治疗多种疾病。更具体地,本发明涉及包含所述衍生物或其盐作为有效成分的药物,该药物用于预防和/或治疗性治疗由GSK3β或GSK3β和cdk5 / p25的异常活性引起的神经变性疾病。阿尔茨海默氏病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号